Hypercalcemia of multiple myeloma has been discussed widely in the medical literature. The role of calcitonin and phosphate in the treatment of hypercalcemia of multiple myeloma has not yet been studied to our knowledge, although experimental animal models have been pointing to the role of phosphate supplement to calcitonin treatment in multiple myeloma. A patient had multiple myeloma and hypercalcemia. The usual medical treatment for hypercalcemia failed; however, the treatment with combined orally administered phosphate and calcitonin was successful. The role of phosphate depletion in this setting is brought up as an important factor in the failure of calcitonin therapy.
(Arch Intern Med 137:914-916, 1977)
Brautbar N, Luboshitzky R. Combined Calcitonin and Oral Phosphate Treatment for Hypercalcemia in Multiple Myeloma. Arch Intern Med. 1977;137(7):914–916. doi:10.1001/archinte.1977.03630190068017
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.